Neurological affectations associated to SARS-CoV-2

Authors

Keywords:

Coronavirus infections, COVID-19, neurologic manifestations

Abstract

Introduction: Coronaviruses are causative agents of respiratory, hepatic, intestinal and neurological diseases. The neurological implications caused by acute respiratory syndrome due to coronavirus 2 have raised several opinions. The clinical involvement and pathophysiologic mechanisms related to neurological complications in patients with COVID-19 are currently poorly understood.
Objective: to describe the neurological involvement associated to SARS-CoV-2 according to its pathophysiopathogenic basis.
Methods: a search was carried out, mainly in PubMed, with the descriptors COVID-19, SARS-CoV-2 and neuro. Scientific journals on the Internet and official Cuban and foreign press media were consulted. The manual published by the Spanish Society of Neurology in April 2020 was reviewed. The analysis-synthesis and historical-logical methods were used when associating the historical neurological affectations of the different coronaviruses with the current one and the deductive inductive method.
Conclusions: the most frequent neurological affectations associated with SARS-CoV-2 are myalgias, headaches, cerebrovascular disease, encephalopathies, encephalitis, Guillain-Barré syndrome, disorders of the senses and consciousness and weakness; they are related to the triggering of inflammatory processes, with alterations caused to the respiratory centers of the brainstem, with mechanisms of muscular damage and with its neuroinvasive potential.

Downloads

Download data is not yet available.

Author Biographies

Fidel Jesús Moreno Cubela, Universidad de Ciencias Médicas de Granma

Estudiante de Medicina

Jesús Daniel de la Rosa Santana, Universidad de Ciencias Médicas de Granma

Estudiante de Medicina

Giselle Lucila Vázquez Gutiérrez, Universidad de Ciencias Médicas de Granma

Especialista de I y II Grado en Pediatría. Profesora Asistente en la Universidad de Ciencias Médicas de Granma.

References

1.Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol [Internet]. 2019 [citado 16/05/2020];17(3):181-92. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097006/. https://dx.doi.org/10.1038/s41579-018-0118-9

2.Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci [Internet]. 2020 [citado 16/05/2020];63(3):457-460. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089049/. https://dx.doi.org/10.1007/s11427-020-1637-5

3.León Castellón R, Bender del Busto JE, Velázquez Pérez LC. Afectación del sistema nervioso por la COVID-19. Anales de la ACC [Internet]. 2020 [citado 16/05/2020];10(2):e760. Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/760/796

4.Sociedad Española de Neurología. Manual COVID-19 para el neurólogo general [Internet]. Madrid: Ediciones SEN; 2020 [citado 16/05/2020]. Disponible en: http://www.sen.es/attachments/article/2677/Manual_neuroCOVID-19_SEN.pdf

5.Titov A, Petukhov A, Staliarova A, Motorin D, Bulatov E, Shuvalov O, et al. The biological basis and clinical symptoms of CAR-T therapy-associated toxicites. Cell Death Dis [Internet]. 2018 [citado 16/05/2020];9(9):897. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123453/. https://dx.doi.org/10.1038/s41419-018-0918-x

6.Al Día. Coronavirus: conclusiones de las primeras autopsias en muertos con COVID-19 [Internet]. La Habana: Infomed; 2020 [citado 19/12/2020]. Disponible en: https://boletinaldia.sld.cu/aldia/2020/04/09/coronavirus-conclusiones-de-las-primeras-autopsias-en-muertos-con-covid-19/

7.Carod-Artal FJ. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol [Internet]. 2020 [citado 16/05/2020];70(9):311-322. Disponible en: https://www.svnps.org/wp-content/uploads/2020/05/bx090311.pdf

8.Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet [Internet]. 2020 [citado 16/05/2020];395(10229):1033-1034. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270045/. https://dx.doi.org/10.1016/S0140-6736(20)30628-0

9.Li Y, Fu L, Gonzales DM, Lavi E. Coronavirus Neurovirulence Correlates with the Ability of the Virus To Induce Proinflammatory Cytokine Signals from Astrocytes and Microglia. J Virol [Internet]. 2004 [citado 16/05/2020];78(7):3398-3406. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC371061/. https://dx.doi.org/10.1128/JVI.78.7.3398-3406.2004

10.Steardo L, Steardo LJr, Zorec R, Verkhratsky A. Neuroinfeccion may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) [Internet]. 2020 [citado 16/05/2020];229(3):e13473. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228251/. https://doi.org/10.1111/apha.13473

11.Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci [Internet]. 2020 [citado 16/05/2020];11(7):995–998. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094171/. https://dx.doi.org/10.1021/acschemneuro.0c00122

12.Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2. J Virol [Internet]. 2008 [citado 16/05/2020];82(15):7264–7275. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493326/. https://doi.org/10.1128/jvi.00737-08

13.Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol [Internet]. 2020 [citado 21/09/2020];92(6):552-555. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228394/. https://doi.org/10.1002/jmv.25728

14.South AM, Diz DI, Chappell MC. COVID-19, ACE2 and the Cardiovascular Consequences. Am J Physiol Hear Circ Physiol [Internet]. 2020 [citado 16/05/2020];318(5):H1084–H1090. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191628/. https://doi.org/10.1152/ajpheart.00217.2020

15.Turtle L. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2. J Med Virol [Internet]. 2020 [citado 21/10/2020];92(7):705-706. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/32246782. https://doi.org/10.1002/jmv.25828

16.Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med [Internet]. 2005 [citado 16/05/2020];202(3):415–424. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213088/. https://dx.doi.org/10.1084/jem.20050828

17.Lang ZW, Zhang LJ, Zhang SJ, Meng X, Li JQ, Song CZ, et al. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology [Internet]. 2003 [citado 16/05/2020];35(6):526-531. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131316/. https://doi.org/10.1080/00313020310001619118

18.Mao L, Jim H, Wang M, Hu Y, Chen S, He Q, et al. Neurological manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol [Internet]. 2020 [citado 16/05/2020];77(6):683-690. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149362/. https://doi.org/10.1001/jamaneurol.2020.1127

19.20minutos. Coronavirus. Regional e Ibima lideran un estudio para conocer afectación neurológica en pacientes con COVID-19 [Internet]. España: 20 Minutos Editora, S.L.; 2020 [citado 16/05/2020]. Disponible en: https://www.20minutos.es/noticia/4256165/0/coronavirus-regional-e-ibima-lideran-un-estudio-para-conocer-afectacion-neurologica-en-pacientes-con-covid-19/

20.BBC News Mundo. Coronavirus: cuáles son los nuevos síntomas que los CDC de EE.UU. agregaron a la lista para la covid-19 [Internet]. Londres: BBC News Mundo; 2020 [citado 16/05/2020]. Disponible en: https://www.bbc.com/mundo/noticias-52459179

21.Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol [Internet]. 2020 [citado 16/05/2020];277(8):2251-2261. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134551/. https://doi.org/10.1007/s00405-020-05965-1

22.Abdennour L, Zeghal C, Dème M, Puybasset L. Interaction brain-lungs. Ann Fr Anesth Reanim [Internet]. 2012 [citado 16/05/2020];31(6):e101-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22694980/. https://doi.org/10.1016/j.annfar.2012.04.013

23.Nath A. Neurologic complications of coronavirus infections. Neurology [Internet]. 2020 [citado 16/05/2020];94(19):809-810. Disponible en: https://n.neurology.org/content/94/19/809. https://doi.org/10.1212/WNL.0000000000009455

24.Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis [Internet]. 2020 [citado 16/05/2020];94:55-58. Disponible en: https://www.sciencedirect.com/science/article/pii/S1201971220301958. https://doi.org/10.1016/j.ijid.2020.03.062

25.Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology [Internet]. 2020 [citado 16/05/2020];296(2):E119-E120. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233386/. https://doi.org/10.1148/radiol.2020201187

26.Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neuro [Internet]. 2020 [citado 16/05/2020];19(5):383–384. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176927/. https://dx.doi.org/10.1016/S1474-4422(20)30109-5

27.Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2.N Engl J Med [Internet]. 2020 [citado 16/05/2020];382(26):2574–2577. Disponible en: https://www.nejm.org/doi/pdf/10.1056/NEJMc2009191. https://doi.org/10.1056/NEJMc2009191

28.Bender del Busto JE, León Castellón R, Mendieta Pedroso MD. Enfermedad cerebrovascular y COVID-19. Anales de la ACC [Internet]. 2020 [citado 16/05/2020];10(2):e802. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/802/832

Downloads

Published

2022-10-01

How to Cite

1.
Moreno Cubela FJ, de la Rosa Santana JD, Vázquez Gutiérrez GL. Neurological affectations associated to SARS-CoV-2. Acta Méd Centro [Internet]. 2022 Oct. 1 [cited 2025 Jul. 14];16(4):770-81. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1704

Issue

Vol. 16 No. 4 (2022): October-December

Section

Review Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).